Article
Blood DNA methylation profiles improve breast cancer prediction.
Molecular oncology - 1 Jan 2022
Kresovich Jacob K, Xu Zongli, O'Brien Katie M, Shi Min, Weinberg Clarice R, Sandler Dale P, Taylor Jack A
Abstract excerpt
Although blood DNA methylation (DNAm) profiles are reported to be associated with breast cancer incidence, they have not been widely used in breast cancer risk assessment. Among a breast cancer case-cohort of 2774 women (1551 cases) in the Sister Study, we used candidate CpGs and DNAm estimators of physiologic characteristics to derive a methylation-based breast cancer risk score, mBCRS. Overall, 19 CpGs and five...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
